ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

CTRC Wins Renewal Of Cancer Center Grant; New Mexico To Lead Systems Biology Center

September 4, 2009

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991